An upstream Oct-1- and Oct-2-binding silencer governs B29 (Igβ) gene expression

Journal of Immunology

Volumn 164, Issue 5, 2000, Pages 2550-2556

  Malone, Cindy Sue ^a   Patrone, Lisa ^a   Buchanan, Kent L ^b,c   Webb, Carol F ^b   Wall, Randolph ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; NUCLEAR PROTEIN; OLIGONUCLEOTIDE;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CELL NUCLEUS MATRIX; CONTROLLED STUDY; DNA BASE COMPOSITION; GENE EXPRESSION REGULATION; IMMUNOGLOBULIN GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA BINDING; SILENCER GENE; TISSUE SPECIFICITY;

EID: 0034162593     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.5.2550     Document Type: Article

References (55)

1. Cambier, J. C., W. Bedzyk, K. Campbell, N. Chien, J. Friedrich, A. Harwood, W. Jensen, C. Pleiman, and M. R. Clark. 1993. The B-cell antigen receptor: structure and function of primary, secondary, tertiary and quaternary components. Immunol. Rev. 132:85.
2. Gong, S., and M. C. Nussenzweig. 1996. Regulation of an early developmental checkpoint in the B cell pathway by Igβ. Science 272:411.
3. Roth, P. E., and A. L. DeFranco. 1996. Receptor tails unlock developmental checkpoints for B lymphocytes. Science 272:1752.
4. Akerblad, P., M. Rosberg, T. Leanderson, and M. Sigvardsson. 1999. The B29 (immunoglobulin β-chain) gene is a genetic target for early B-cell factor. Mol. Cell. Biol. 19:392.
5. Omori, S. A., and R. Wall. 1993. Multiple motifs regulate the B-cell-specific promoter of the B29 gene. Proc. Natl. Acad. Sci. USA 90:11723.
6. Hermanson, G. G., M. Briskin, D. Sigman, and R. Wall. 1989. Immunoglobulin enhancer and promoter motifs 5′ of the B29 B-cell-specific gene. Proc. Natl. Acad. Sci. USA 86:7341.
7. Malone, C., S. A. Omori, and R. Wall. 1997. Silencer elements controlling the murine B29 (Ig-b) promoter are neither promoler nor cell-type specific. Proc. Natl. Acad. Sci. USA 94:12314.
8. Young, R. L., and S. J. Korsmeyer. 1993. A negative regulatory element in the bcl-2 5′-untranslated region inhibits expression from an upstream promoter. Mol. Cell. Biol. 13:3686.
9. Chen, J. H., S. Jeha, and T. Oka. 1993. Negative regulatory elements in the human ETS1 gene promoter. Oncogene 8:133.
10. Yang, J., M. A. Glozak, and B. B. Blomberg. 1995. Identification and localization of a developmental stage-specific promoter activity from the murine λ5 gene. J. Immunol. 155:2498.
11. Hanada, M., D. Delia, A. Aiello, E. Stadtmauer, and J. C. Reed. 1993. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820.
12. Korsmeyer, S. J. 1992. Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 80:879.
13. Wang, B., C. Levelt, M. Salio, D. Zheng, J. Sancho, C. P. Liu, J. She, M. Huang, K. Higgins, M. J. Sunshine, et al. 1995. Over-expression of CD3∈ transgenes blocks T lymphocyte development. Int. Immunol. 7:435.
14. Wang, B., J. She, M. Salio, D. Allen, E. Lacy, N. Lonberg, and C. Terhorst. 1997. CD3∈ overexpressed in prothymocytes acts as an oncogene. Mol. Med. 3:72.
15. Baumruker, T., R. Sturm, and W. Herr. 1988. OBP100 binds remarkably degenerate octamer motifs through specific interactions with flanking sequences. Genes Dev. 2:1400.
16. Gasser, S. M., B. B. Amati, M. E. Cardenas, and J. F. Hofmann. 1989. Studies on scaffold attachment sites and their relation to genome function. Int. Rev. Cytol. 119:57.
17. Verheijen, R., W. van Venrooij, and F. Ramaekers. 1988. The nuclear matrix: structure and composition. J. Cell Sci. 90:11.
18. Bode, J., and K. Maass. 1988. Chromatin domain surrounding the human interferon-β gene as defined by scaffold-attached regions. Biochemistry 27:4706.
19. Cockerill, P. N., M. H. Yuen, and W. T. Garrard. 1987. The enhancer of the immunoglobulin heavy chain locus is flanked by presumptive chromosomal loop anchorage elements. J. Biol. Chem. 262:5394.
20. Gasser, S. M., and U. K. Laemmli. 1986. Cohabitation of scaffold binding regions with upstream/enhancer elements of three developmentally regulated genes of D. melanogaster. Cell 46:521.
21. Jarman, A. P., and D. R. Higgs. 1988. Nuclear scaffold attachment sites in the human globin gene complexes. EMBO J. 7:3337.
22. Loc, P. V., and W. H. Stratling. 1988. The matrix attachment regions of the chicken lysozyme gene co-map with the boundaries of the chromatin domain. EMBO J. 7:655.
23. Garrard, W. T. 1991. Histone H1 and the conformation of transcriptionally active chromatin. BioEssays 13:87.
24. Grosveld, F., G. B. van Assendelft, D. R. Greaves, and G. Kollias. 1987. Position-independent, high-level expression of the human beta-globin gene in transgenic mice. Cell 51:975.
25. Cockerill, P. N., and W. T. Garrard. 1986. Chromosomal loop anchorage sites appear to be evolutionary conserved. FEBS Lett. 204:5.
26. Forrester, W. C., C. van Genderen, T. Jenuwein, and R. Grosschedl. 1994. Dependence of enhancer-mediated transcription of the immunoglobulin μ gene on nuclear matrix attachment regions. Science 265:1221.
27. McKnight, R. A., A. Shamay, L. Sankaran, R. J. Wall, and L. Hennighausen. 1992. Matrix-attachment regions can impart position-independent regulation of a tissue-specific gene in transgenic mice. Proc. Natl. Acad. Sci. USA 89:6943.
28. Grosschedl, R., and D. Baltimore. 1985. Cell-type specificity of immunoglobulin gene expression is regulated by at least three DNA sequence elements. Cell 41: 885.
29. Lo, K., N. R. Landau, and S. T. Smale. 1991. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol. Cell. Biol. 11:5229.
30. Cockerill, P. N., and W. T. Garrard. 1986. Chromosomal loop anchorage of the kappa immunoglobulin gene occurs next to the enhancer in a region containing topoisomerase II sites. Cell 44:273.
31. Webb, C. F., C. Das, K. L. Eneff, and P. W. Tucker. 1991. Identification of a matrix-associated region 5′ of an immunoglobulin heavy chain variable region gene. Mol. Cell. Biol. 11:5206.
32. Dickinson, L. A., T. Joh, Y. Kohwi, and T. Kohwi-Shigematsu. 1992. A tissue-specific MAR/SAR DNA-binding protein with unusual binding site recognition. Cell 70:631.
33. Kim, M. K., L. A. Lesoon-Wood, B. D. Weintraub, and J. H. Chung. 1996. A soluble transcription factor, Oct-1, is also found in the insoluble nuclear matrix and possesses silencing activity in its alanine-rich domain. Mol. Cell. Biol. 16: 4366.
34. Bhat, R., J. A. Weaver, K. M. Sterling, and E. Bresnick. 1996. Nuclear transcription factor Oct-1 binds to the 5′-upstream region of CYP1A1 and negatively regulates its expression. Int. J. Biochem. Cell Biol. 28:217.
35. de Grazia, U., M. P. Felli, A. Vacca, A. R. Farina, M. Maroder, L. Cappabianca, D. Meco, M. Farina, I. Screpanti, L. Frati, et al. 1994. Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1. Oct-2, and retinoic acid receptor. J. Exp. Med. 180:1485.
36. Delhase, M., J. L. Castrillo, M. de la Hoya, F. Rajas, and E. L. Hooghe-Peters. 1996. AP-1 and Oct-1 transcription factors down-regulate the expression of the human PIT1/GHF1 gene. J. Biol. Chem. 271:32349.
37. Banerji, J., L. Olson, and W. Schaffner. 1983. A lymphocyte-specific cellular enhancer is located downstream of the joining region in immunoglobulin heavy chain genes. Cell 33:729.
38. Gillies, S. D., S. L. Morrison, V. T. Oi, and S. Tonegawa. 1983. A tissue-specific transcription enhancer element is located in the major intron of a rearranged immunoglobulin heavy chain gene. Cell 33:717.
39. Queen, C., and D. Baltimore. 1983. Immunoglobulin gene transcription is activated by downstream sequence elements. Cell 33:741.
40. Herrscher, R. F., M. H. Kaplan, D. L. Lelsz, C. Das, R. Scheuermann, and P. W. Tucker. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9:3067.
41. Webb, C. F., C. Das, S. Eaton, K. Calame, and P. W. Tucker. 1991. Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol. 11:5197.
42. Webb, C. F., K. L. Eneff, and F. H. Drake. 1993. A topoisomerase 11-like protein is part of an inducible DNA-binding protein complex that binds 5′ of an immunoglobulin promoter. Nucleic Acids Res. 21:4363.
43. Dawson, S. J., S. O. Yoon, D. M. Chikaraishi, K. A. Lillycrop, and D. S. Latchman. 1994. The Oct-2 transcription factor represses tyrosine hydroxylase expression via a heptamer TAATGARAT-like motif in the gene promoter. Nucleic Acids Res. 22:1023.
44. Lillycrop, K. A., S. J. Dawson, J. K. Estridge, T. Gerster, P. Matthias, and D. S. Latchman. 1994. Repression of a herpes simplex virus immediate-early promoter by the Oct-2 transcription factor is dependent on an inhibitory region at the N terminus of the protein. Mol. Cell. Biol. 14:7633.
45. Liu, Y. Z., and D. S. Latchman. 1997. The octamer-binding proteins Oct-1 and Oct-2 repress the HIV long terminal repeat promoter and its transactivation by Tat. Biochem. J. 322:155.
46. Luo, Y., H. Fujii, T. Gerster, and R. G. Roeder. 1992. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell 71:231.
47. Strubin, M., J. W. Newell, and P. Matthias. 1995. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell 80:497.
48. Gstaiger, M., L. Knoepfel, O. Georgiev, W. Schaffner, and C. M. Hovens. 1995. A B-cell coactivator of octamer-binding transcription factors. Nature 373:360.
49. Kim, J. S., J. Kim, K. L. Cepek, P. A. Sharp, and C. O. Pabo. 1997. Design of TATA box-binding protein/zinc finger fusions for targeted regulation of gene expression. Proc. Natl. Acad. Sci. USA 94:3616.
50. Cepek, K. L., D. I. Chasman, and P. A. Sharp. 1996. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B. Genes Dev. 10:2079.
51. Gstaiger, M., O. Georgiev, H. van Leeuwen, P. van der Vliet, and W. Schaffner. 1996. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15:2781.
52. Kramer, J. A., and S. A. Krawetz. 1997. PCR-based assay to determine nuclear matrix association. BioTechniques 22:826.
53. Kramer, J. A., M. D. Adams, G. B. Singh, N. A. Doggett, and S. A. Krawetz. 1998. A matrix associated region localizes the human SOCS-1 gene to chromosome 16p13. 13. Somatic Cell Mol. Genet. 24:131.
54. Ortiz, B. D., D. Cado, V. Chen, P. W. Diaz, and A. Winoto. 1997. Adjacent DNA elements dominantly restrict the ubiquitous activity of a novel chromatin-opening region to specific tissues. EMBO J. 16:5037.
55. van Wijnen, A. J., J. P. Bidwell, E. G. Fey, S. Penman, J. B. Lian, J. L. Stein, and G. S. Stein. 1993. Nuclear matrix association of multiple sequence-specific DNA binding activities related to SP-1, ATF, CCAAT, C/EBP, OCT-1, and AP-1. Biochemistry 32:8397.